Author:
Scheithauer Mindy,Muething Colin,Gerencser Kristina R.,Call Nathan A.
Publisher
Springer International Publishing
Reference163 articles.
1. Adamsen, D., Ramaekers, V., Ho, H. T. B., Britschgi, C., Rufenacht, V., Meili, D., … Thony, B. (2014). Autism spectrum disorder associated with low serotonin in CSF and mutations in the SLC29A4 plasma membrane monoamine transporter (PMAT) gene. Molecular Autism, 5. https://doi.org/10.1186/2040-2392-5-43
2. Allen, D. G., Lowe, K., Moore, K., & Brophy, S. (2007). Predictors, costs and characteristics of out of area placement for people with intellectual disability and challenging behaviour. Journal of Intellectual Disability Research, 51(6), 409–416.
3. Aman, M. G., De Smedt, G., Derivan, A., Lyons, B., Findling, R. L., & Risperidone Disruptive Behavior Study Group. (2002). Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. American Journal of Psychiatry, 159(8), 1337–1346.
4. Anderson, L. T., & Ernst, M. (1994). Self-injury in Lesch-Nyhan disease. Journal of Autism and Developmental Disorders, 24(1), 67–81.
5. Arendt, R. E., MacLean, W. E., & Baumeister, A. A. (1988). Critique of sensory integration therapy and its application in mental retardation. American Journal on Mental Retardation, 92, 401–411.